Alternative Health Powered by Trendolizer

FDA Adds Boxed Warning to Canagliflozin for Amputation Risk

Trending story found on
On the basis of new information from two cardiovascular outcomes trials suggesting a doubled amputation risk, the FDA will now require a boxed warning on canagliflozin's label.
[Source:] [ Comments ] [See why this is trending]

Trend graph: